Global Influenza Market Worth USD 10.2 Billion by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Abbott, CSL, Roche - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Influenza Market - Vaccines and Therapeutics" report to their offering.

Worldwide market for Influenza Vaccines is analyzed in both volumes in doses and value in USD for the period from 2012 through to 2022. The market for influenza therapeutics is analyzed in terms of value only at a global level. The global market for overall influenza is estimated to be US$6.1 billion in 2016 and anticipated to reach US$10.2 billion by 2022, witnessing a robust 8.5% CAGR between 2016 and 2022. Vaccines account for about 80% of the influenza market while therapeutics account for the remaining. However, therapeutics segment is projected to be the fastest growing with a CAGR of 11% during the aforementioned analysis period.

The report reviews, analyses and projects the Influenza therapeutics market at the global level while vaccines market is explored in and the regional markets including North America, Europe, Asia-Pacific, South & Central America and Middle East & Africa.

Companies Mentioned:

  • Abbott Laboratories
  • Astrazeneca PLC
  • Biocryst Pharmaceuticals, Inc.
  • CSL Limited
  • Daiichi Sankyo Co., Ltd.
  • Glaxosmithkline PLC
  • Hualan Biological Engineering Inc.
  • Instituto Butantan
  • Mitsubishi Tanabe Pharma Corporation
  • Nanotherapeutics Inc.
  • Protein Sciences Corporation
  • Roche Holding AG
  • Sanofi SA
  • Shanghai Institute of Biological Products Co., Ltd.
  • Shionogi & Co., Ltd.
  • Sinovac Biotech Ltd.

Report Structure:

Part A: Global Market Perspective

1. Introduction

2. Major Products In Pipeline

3. Key Market Trends

4. Key Global Players

5. Key Business Trends

6. Global Market Overview

Part B: Regional Market Perspective

Regional Market Overview

1. North America

2. Europe

3. Asia-Pacific

4. South & Central America

5. Middle East & Africa

Part C: Guide To The Industry

1. North America

2. Europe

3. Asia-Pacific

4. Rest Of World

Part D: Annexure

1. Research Methodology

2. Feedback

For more information visit http://www.researchandmarkets.com/research/xvmhnc/global_influenza

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases, Vaccines

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases, Vaccines